-
1 Comment
Wuhan Hiteck Biological Pharma Co., Ltd is currently in a long term uptrend where the price is trading 2.7% above its 200 day moving average.
From a valuation standpoint, the stock is 18.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 7.9.
Wuhan Hiteck Biological Pharma Co., Ltd's total revenue rose by 3.0% to $156M since the same quarter in the previous year.
Its net income has dropped by 154.8% to $-7M since the same quarter in the previous year.
Finally, its free cash flow fell by 137.2% to $-22M since the same quarter in the previous year.
Based on the above factors, Wuhan Hiteck Biological Pharma Co., Ltd gets an overall score of 3/5.
CurrencyCode | CNY |
---|---|
Exchange | SHE |
ISIN | CNE1000034C5 |
Industry | Drug Manufacturers-Specialty & Generic |
Sector | Healthcare |
PE Ratio | 165.13 |
---|---|
Target Price | None |
Dividend Yield | 0.0% |
Beta | -0.19 |
Market Cap | 5B |
Wuhan Hiteck Biological Pharma Co.,Ltd, a biopharmaceutical company, engages in the research and development, production, and sale of bio engineering products and freeze-dried powder injection in China. Its products include Jinlujie, a mouse nerve growth factor for injection; omeprazole sodium for injection; cyclic adenosine phosphate; Xinye, an acyclovir dispensable tablets; Bingbing Horse & Dragon, an indomethacin furazolidone suppository drug; Xunkeyuan, a tinidazole suppository drug; and Shufu, a nimodipine sustained release tablets. The company also provides measles virus and rubella virus nucleic acid detection kit; mycoplasma isolation and identification kit and culture tube; bacterial vaginosis rapid detection kit; measles virus IgG antibody detection kit; and coronavirus N-protein detection kit. In addition, it offers Lopinavir and Ritonavir APIs; and intermediates. The company offers its products in the field of nervous system and oncology. Wuhan Hiteck Biological Pharma Co.,Ltd was founded in 1992 and is based in Wuhan, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 300683.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024